Christopher Pittenger Selected Research

Histidine Decarboxylase

1/2020	The histidine decarboxylase model of tic pathophysiology: a new focus on the histamine H3 receptor.
11/2018	Striatal Signaling Regulated by the H3R Histamine Receptor in a Mouse Model of tic Pathophysiology.
1/2017	Histidine Decarboxylase Knockout Mice as a Model of the Pathophysiology of Tourette Syndrome and Related Conditions.
1/2017	Histamine modulation of the basal ganglia circuitry in the development of pathological grooming.
5/2015	Histidine decarboxylase knockout mice, a genetic model of Tourette syndrome, show repetitive grooming after induced fear.
1/2014	Histidine decarboxylase deficiency causes tourette syndrome: parallel findings in humans and mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christopher Pittenger Research Topics

Disease

20	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 09/2005
7	Tourette Syndrome (Tourette's Syndrome) 01/2020 - 01/2014
6	Tics (Tic) 01/2020 - 01/2014
4	Mental Disorders (Mental Disorder) 01/2022 - 01/2005
3	Tic Disorders (Tic Disorder) 01/2020 - 01/2016
3	Trichotillomania 03/2013 - 01/2007
2	Schizophrenia (Dementia Praecox) 01/2021 - 01/2016
2	Neurodevelopmental Disorders 01/2021 - 01/2019
2	Inflammation (Inflammations) 10/2016 - 06/2008
2	Nausea 08/2015 - 01/2008
2	Bipolar Disorder (Manic Depressive Psychosis) 07/2013 - 01/2008
2	Major Depressive Disorder (Major Depressive Disorders) 07/2013 - 04/2007
2	Anxiety Disorders (Anxiety Disorder) 06/2011 - 01/2008
2	Alzheimer Disease (Alzheimer's Disease) 11/2010 - 06/2008
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2008 - 01/2006
1	Autism Spectrum Disorder 01/2021
1	Telomeric 22q13 Monosomy Syndrome 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Dyskinesias (Dyskinesia) 01/2019
1	Alcoholism (Alcohol Abuse) 01/2017
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2016
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2016
1	Narcolepsy 01/2016
1	Seizures (Absence Seizure) 03/2015
1	Respiratory Insufficiency (Respiratory Failure) 07/2013
1	Mood Disorders (Mood Disorder) 06/2011
1	Dementia (Dementias) 06/2008
1	Alcohol Withdrawal Delirium (Delirium Tremens) 03/2007
1	Excoriation Disorder 12/2006
1	Hallucinations (Hallucination) 04/2006
1	Borderline Personality Disorder (Personality Disorders, Borderline) 11/2005

Drug/Important Bio-Agent (IBA)

9	Glutamic Acid (Glutamate)FDA Link 07/2017 - 11/2005
8	Riluzole FDA LinkGeneric 08/2015 - 09/2005
6	Histamine (Histamine Dihydrochloride)FDA Link 01/2020 - 01/2016
6	Histidine DecarboxylaseIBA 01/2020 - 01/2014
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 07/2017 - 01/2006
3	Acetylcysteine (Siran)FDA LinkGeneric 07/2017 - 01/2006
3	Ketamine FDA LinkGeneric 01/2017 - 12/2012
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2008
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2008
2	Histamine Receptors (Histamine Receptor)IBA 11/2018 - 01/2016
2	EnzymesIBA 01/2017 - 01/2017
2	Dextroamphetamine (Dexedrine)FDA LinkGeneric 05/2015 - 01/2015
2	Dopamine (Intropin)FDA LinkGeneric 01/2014 - 06/2011
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2013 - 04/2007
1	Hallucinogens (Psychedelics)IBA 01/2022
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2019
1	AntioxidantsIBA 07/2017
1	Nonsense Codon (Nonsense Mutation)IBA 01/2017
1	pitolisantIBA 01/2016
1	Pharmacologic ActionsIBA 01/2016
1	PicrotoxinIBA 03/2015
1	GABA-A Receptors (GABA(A) Receptor)IBA 03/2015
1	MuscimolIBA 03/2015
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2015
1	Cholinergic Agents (Cholinergics)IBA 01/2015
1	Haloperidol (Haldol)FDA LinkGeneric 01/2014
1	Hypnotics and Sedatives (Sedatives)IBA 07/2013
1	Antidepressive Agents (Antidepressants)IBA 07/2013
1	IGF-I-IGFBP-3 complex FDA Link 06/2011
1	GoldIBA 06/2011
1	Tyrosine (L-Tyrosine)FDA Link 11/2010
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2010
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 09/2008
1	Amyloid beta-PeptidesIBA 06/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2008
1	CytokinesIBA 06/2008
1	Transforming Growth Factor beta (TGF-beta)IBA 06/2008
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 06/2008
1	Amyloid (Amyloid Fibrils)IBA 06/2008
1	Amino Acids FDA Link 01/2008
1	Clomipramine (Anafranil)FDA LinkGeneric 10/2007
1	Gabapentin (Neurontin)FDA LinkGeneric 03/2007
1	Bupropion (Wellbutrin)FDA LinkGeneric 04/2006
1	Memantine (Namenda)FDA Link 04/2006
1	Biological ProductsIBA 01/2005

Therapy/Procedure

7	Therapeutics 01/2021 - 09/2005
5	Drug Therapy (Chemotherapy) 01/2021 - 01/2005
2	Transcranial Direct Current Stimulation 01/2022 - 11/2021
1	Neurofeedback 01/2014
1	Off-Label Use 07/2013
1	Anesthesia 07/2013